Kati Elima

3.0k total citations
53 papers, 2.3k citations indexed

About

Kati Elima is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Kati Elima has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Oncology and 16 papers in Immunology and Allergy. Recurrent topics in Kati Elima's work include Cell Adhesion Molecules Research (16 papers), Microbial metabolism and enzyme function (11 papers) and Lymphatic System and Diseases (10 papers). Kati Elima is often cited by papers focused on Cell Adhesion Molecules Research (16 papers), Microbial metabolism and enzyme function (11 papers) and Lymphatic System and Diseases (10 papers). Kati Elima collaborates with scholars based in Finland, United States and United Kingdom. Kati Elima's co-authors include Marko Salmi, Sirpa Jalkanen, Eero Vuorio, Marika Karikoski, Pia Rantakari, Fumiko Marttila‐Ichihara, Kaisa Auvinen, Tiina Henttinen, Heidi Gerke and Gennady G. Yegutkin and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Kati Elima

52 papers receiving 2.2k citations

Peers

Countries citing papers authored by Kati Elima

Since Specialization

Citations

This map shows the geographic impact of Kati Elima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kati Elima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kati Elima more than expected).

Fields of papers citing papers by Kati Elima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kati Elima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kati Elima. The network helps show where Kati Elima may publish in the future.

Co-authorship network of co-authors of Kati Elima

This figure shows the co-authorship network connecting the top 25 collaborators of Kati Elima. A scholar is included among the top collaborators of Kati Elima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kati Elima. Kati Elima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast cancer remodels lymphatics in sentinel lymph nodes 2025 ·Nature Communications ·(unknown), (unknown), Anni Kauko, (unknown), (unknown), Kati Elima, Minna Piipponen, Tapio Lönnberg, Pia Boström, Ilkka Koskivuo, Tero Aittokallio, Maija Hollmén, Akira Takeda, Sirpa Jalkanen	0
2	Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19 2023 ·Critical Care ·Juho Jalkanen, Sofia Khan, Kati Elima, Teppo Huttunen, (unknown), Maija Hollmén, Laura L. Elo, Sirpa Jalkanen	15
3	Robo4 contributes to the turnover of Peyer's patch B cells 2019 ·Mucosal Immunology ·(unknown), Milas Ugur, (unknown), (unknown), (unknown), (unknown), Kati Elima, Masayuki Miyasaka, Oliver Pabst, Sirpa Jalkanen	4
4	Fetal liver endothelium regulates the seeding of tissue-resident macrophages 2016 ·Nature ·Pia Rantakari, (unknown), (unknown), (unknown), Heidi Gerke, Emilia Peuhu, Johanna Ivaska, Kati Elima, Kaisa Auvinen, Marko Salmi	64
5	The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes 2015 ·Nature Immunology ·Pia Rantakari, Kaisa Auvinen, (unknown), (unknown), (unknown), Marika Karikoski, Heidi Gerke, (unknown), (unknown), Eiji Umemoto, Kazuo Tohya, Masayuki Miyasaka, Kati Elima, Sirpa Jalkanen, Marko Salmi	156
6	Clever-1/Stabilin-1 Controls Cancer Growth and Metastasis 2014 ·Clinical Cancer Research ·Marika Karikoski, Fumiko Marttila‐Ichihara, Kati Elima, Pia Rantakari, Maija Hollmén, Tiina Kelkka, Heidi Gerke, Ville Huovinen, Heikki Irjala, Rikard Holmdahl, Marko Salmi, Sirpa Jalkanen	77
7	Adenosine Inhibits Tumor Cell Invasion via Receptor-Independent Mechanisms 2014 ·Molecular Cancer Research ·(unknown), (unknown), Minna Vainio, Kati Elima, Pirkko Härkönen, Sirpa Jalkanen, Gennady G. Yegutkin	44
8	Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs 2014 ·Mediators of Inflammation ·Gennady G. Yegutkin, Kaisa Auvinen, Marika Karikoski, Pia Rantakari, Heidi Gerke, Kati Elima, Mikael Maksimow, Ileana B. Quintero, Pirkko Vihko, Marko Salmi, Sirpa Jalkanen	16
9	Early Prediction of Persistent Organ Failure by Soluble CD73 in Patients With Acute Pancreatitis 2014 ·WOS ·Mikael Maksimow, (unknown), (unknown), Leena Kylänpää, Kristiina Aalto, Kati Elima, Panu Mentula, Mari S. Lehti, Pauli Puolakkainen, Gennady G. Yegutkin, Sirpa Jalkanen, Heikki Repo, Marko Salmi	2
10	Early Prediction of Persistent Organ Failure by Soluble CD73 in Patients With Acute Pancreatitis* 2014 ·Critical Care Medicine ·Mikael Maksimow, (unknown), (unknown), Leena Kylänpää, Kristiina Aalto, Kati Elima, Panu Mentula, Mari S. Lehti, Pauli Puolakkainen, Gennady G. Yegutkin, Sirpa Jalkanen, Heikki Repo, Marko Salmi	41
11	Altered purinergic signaling in CD73‐deficient mice inhibits tumor progression 2011 ·European Journal of Immunology ·Gennady G. Yegutkin, Fumiko Marttila‐Ichihara, Marika Karikoski, Jussi Niemelä, Juha P. Laurila, Kati Elima, Sirpa Jalkanen, Marko Salmi	127
12	Vascular Adhesion Protein-1 Enhances Tumor Growth by Supporting Recruitment of Gr-1+CD11b+ Myeloid Cells into Tumors 2009 ·Cancer Research ·Fumiko Marttila‐Ichihara, Kaisa Auvinen, Kati Elima, Sirpa Jalkanen, Marko Salmi	57
13	Vascular Adhesion Protein-1 Enhances Tumor Growth by Supporting Recruitment of Gr-1(+)CD11b(+) Myeloid Cells into Tumors 2009 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Fumiko Marttila‐Ichihara, Kaisa Auvinen, Kati Elima, Sirpa Jalkanen, Marko Salmi	1
14	Clever‐1/Stabilin‐1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation 2009 ·European Journal of Immunology ·Marika Karikoski, Heikki Irjala, Mikael Maksimow, Mari Miiluniemi, Kaisa Granfors, (unknown), Kati Elima, Gerhard Moldenhauer, Kai Schledzewski, Julia Kzhyshkowska, Sergij Goerdt, Marko Salmi, Sirpa Jalkanen	75
15	The unique substrate specificity of human AOC2, a semicarbazide-sensitive amine oxidase 2009 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), (unknown), Heidi Kidron, (unknown), Tiina A. Salminen, Marko Salmi, Sirpa Jalkanen, Kati Elima	28
16	The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels 2003 ·European Journal of Immunology ·Heikki Irjala, Kati Elima, (unknown), (unknown), (unknown), Kalle Alanen, Reidar Grénman, Marko Salmi, Sirpa Jalkanen	101
17	Tissue Distribution and Phenotypic Consequences of Different Type X Collagen Gene Constructs in Transgenic Mice 1996 ·Annals of the New York Academy of Sciences ·Iiro Eerola, Kati Elima, Merja Markkula, Kirsi Kananen, Eero Vuorio	10
18	Osteoinductive Proteins 1993 ·Annals of Medicine ·Kati Elima	25
19	Specific hybridization probes for mouse α2(IX) and α1(X) collagen mRNAs 1992 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Kati Elima, Marjo Metsäranta, Johanna Kallio, Merja Perälä, Iiro Eerola, Silvio Garofalo, Benoît De Crombrugghe, Eero Vuorio	26
20	Polymorphic Restriction Sites of Type II Collagen Gene: Their Location and Frequencies in the Finnish Population 1988 ·Human Heredity ·(unknown), Kati Elima, Aarno Palotie, Laura‐Maria Peltonen, Eero Vuorio	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact